H. Lundbeck and Contera Pharma have announced a research partnership in new oligonucleotide-based therapies for neurological ...

Dermatology is thriving with innovation, from smart oral drugs to gene-therapy based fixes for rare skin diseases and skin ...

The complex and costly journey of oncology drug development is reliant on robust and comprehensive clinical data. Early-stage ...

The US FDA has granted approval for Roche's Gazyva/ Gazyvaro to treat adult patients with active LN who are on standard ...

The US Food and Drug Administration (FDA) has approved Glaukos Corporation’s Epioxa, offering patients living with a rare ...

J&J will now explore Rybrevant's efficacy and safety in a Phase III trial in first-line, EGFR-driven HNSCC and colorectal ...

Paul Hastings and TriLegal have emerged as the leading mergers and acquisitions (M&A) legal advisers in the Asia-Pacific ...

A&O Shearman and CMS have emerged as the top legal advisers in terms of deal value and deal volume, respectively.

Goldman Sachs and UBS have secured their positions as the leading mergers and acquisitions (M&A) financial advisers in the ...

Wachtell, Lipton, Rosen & Katz and Kirkland & Ellis have emerged as the top M&A legal advisers in North America in terms of ...

Goldman Sachs and Houlihan Lokey have emerged as the leading mergers and acquisitions (M&A) financial advisers in North ...

Bank of America and Rothschild & Co have secured the leading positions as financial advisers in Europe's M&A sector.